MCC950 was injected every other day into the wound in C57BL/6 diabetic mice.
MCC950 increased M2 macrophages and decreased pro-inflammatory genes. MCC950 recruits MDSCs and significantly accelerates diabetic wound healing.
Resveratrol effects on macrophage polarization and wound healing [55]
Diabetic mice modelTHP1 cells
Diabetes was induced with STZ in C57BL/6 mice.THP1 cells were used to evaluate the effects of resveratrol on polarization and the secretion of pro-inflammatory factors.
Resveratrol significantly increased diabetic wound healing.Resveratrol reduces TNF-α, iNOS, and IL-1β secretion and promotes M2 macrophage polarization.
Diabetes was induced using streptozotocin in mice.Puerarin (120 mg/kg i.p.) was administered daily to the mice
Induces M2 macrophage polarization.The effects of puerarin on macrophage polarization are related to NF-κB and MAPK signaling pathways.Puerarin promotes diabetic wound healing.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Srinivas-Shankar U, Kimyaghalam A, Bergman R. Diabetic Foot Ulceration and Complications. StatPearls: StatPearls Publishing; 2025.
Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: A Review.JAMA. 2023;330:62–75. [DOI] [PubMed] [PMC]
McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers.Diabetes Care. 20223;46:209–21. [DOI] [PubMed] [PMC]
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis.Ann Med. 2017;49:106–16. [DOI] [PubMed]
Wernecke J, Wernecke M, Ebenau O, Spruth B, Krämer M, Vogelmann T, et al. Epidemiology and the Medical Burden of Diabetic Foot Ulcers Especially in Patients With Infection—A Population‐Based Analysis From Germany.Int Wound J. 2025;22:e70157. [DOI] [PubMed] [PMC]
Lim JZ, Ng NS, Thomas C. Prevention and treatment of diabetic foot ulcers.J R Soc Med. 2017;110:104–9. [DOI] [PubMed] [PMC]
Everett E, Mathioudakis N. Update on management of diabetic foot ulcers.Ann N Y Acad Sci. 2018;1411:153–65. [DOI] [PubMed] [PMC]
Rai V, Moellmer R, Agrawal DK. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.Mol Biol Rep. 2022;49:1565–72. [DOI] [PubMed]
Smith J, Rai V. Platelet-Rich Plasma in Diabetic Foot Ulcer Healing: Contemplating the Facts.Int J Mol Sci. 2024;25:12864. [DOI] [PubMed] [PMC]
Dawi J, Tumanyan K, Tomas K, Misakyan Y, Gargaloyan A, Gonzalez E, et al. Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies.Biomedicines. 2025;13:1076. [DOI] [PubMed] [PMC]
Cioce A, Cavani A, Cattani C, Scopelliti F. Role of the Skin Immune System in Wound Healing.Cells. 2024;13:624. [DOI] [PubMed] [PMC]
Chesko DM, Wilgus TA. Immune Cells in Cutaneous Wound Healing: A Review of Functional Data from Animal Models.Int J Mol Sci. 2022;23:2444. [DOI] [PubMed] [PMC]
Raziyeva K, Kim Y, Zharkinbekov Z, Kassymbek K, Jimi S, Saparov A. Immunology of Acute and Chronic Wound Healing.Biomolecules. 2021;11:700. [DOI] [PubMed] [PMC]
Kandhwal M, Behl T, Singh S, Sharma N, Arora S, Bhatia S, et al. Role of matrix metalloproteinase in wound healing.Am J Transl Res. 2022;14:4391–405. [PubMed]
Singh G, Chaudhry Z, Nigam S, Shoha D, Rai V. Inflammation, Fibrosis, and Innate Immune Response in Diabetic Foot Ulcer.In: Management and Strategies for Wound Healing. Springer; 2026. pp. 237–58. [DOI]
Wang J, Yang X, Zhou T, Ma H, Yuan X, Yan S, et al. Microenvironment of diabetic foot ulcers: Implications for healing and therapeutic strategies.J Res Med Sci. 2025;30:19. [DOI] [PubMed] [PMC]
Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing.Nat Med. 2015;21:815–9. [DOI] [PubMed] [PMC]
Fadini GP, Menegazzo L, Rigato M, Scattolini V, Poncina N, Bruttocao A, et al. NETosis Delays Diabetic Wound Healing in Mice and Humans.Diabetes. 2016;65:1061–71. [DOI] [PubMed]
Yang S, Wang S, Chen L, Wang Z, Chen J, Ni Q, et al. Neutrophil Extracellular Traps Delay Diabetic Wound Healing by Inducing Endothelial-to-Mesenchymal Transition via the Hippo pathway.Int J Biol Sci. 2023;19:347–61. [DOI] [PubMed] [PMC]
Yang S, Gu Z, Lu C, Zhang T, Guo X, Xue G, et al. Neutrophil Extracellular Traps Are Markers of Wound Healing Impairment in Patients with Diabetic Foot Ulcers Treated in a Multidisciplinary Setting.Adv Wound Care (New Rochelle). 2020;9:16–27. [DOI] [PubMed] [PMC]
Li Y, Li X, Ju S, Li W, Zhou S, Wang G, et al. Role of M1 macrophages in diabetic foot ulcers and related immune regulatory mechanisms.Front Pharmacol. 2022;13:1098041. [DOI] [PubMed] [PMC]
Zhang J, Li H, Dong Y, Zhou Z, Wang Y, Chen X, et al. Insights Into Macrophage Polarization and M1/M2 Balance in Diabetic Foot Ulcers.J Diabetes. 2026;18:e70205. [DOI] [PubMed] [PMC]
Wu X, He W, Mu X, Liu Y, Deng J, Liu Y, et al. Macrophage polarization in diabetic wound healing.Burns Trauma. 2022;10:tkac051. [DOI] [PubMed] [PMC]
Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance.Front Immunol. 2014;5:614. [DOI] [PubMed] [PMC]
Rai V, Moellmer R, Agrawal DK. Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer.Mol Biol Rep. 2023;50:1913–29. [DOI] [PubMed]
Littig JPB, Moellmer R, Estes AM, Agrawal DK, Rai V. Increased Population of CD40+ Fibroblasts Is Associated with Impaired Wound Healing and Chronic Inflammation in Diabetic Foot Ulcers.J Clin Med. 2022;11:6335. [DOI] [PubMed] [PMC]
Chen R, Zou L. Combined analysis of single-cell sequencing and bulk transcriptome sequencing reveals new mechanisms for non-healing diabetic foot ulcers.PLOS ONE. 2024;19:e0306248. [DOI] [PubMed] [PMC]
Wang HH, Korah M, Jing SL, Berry CE, Griffin MF, Longaker MT, et al. Characterizing Fibroblast Heterogeneity in Diabetic Wounds Through Single-Cell RNA-Sequencing.Biomedicines. 2024;12:2538. [DOI] [PubMed] [PMC]
Gumede DB, Abrahamse H, Houreld NN. Targeting Wnt/β-catenin signaling and its interplay with TGF-β and Notch signaling pathways for the treatment of chronic wounds.Cell Commun Signal. 2024;22:244. [DOI] [PubMed] [PMC]
Wang KY, Yamada S, Izumi H, Tsukamoto M, Nakashima T, Tasaki T, et al. Critical in vivo roles of WNT10A in wound healing by regulating collagen expression/synthesis in WNT10A-deficient mice.PLOS ONE. 2018;13:e0195156. [DOI] [PubMed] [PMC]
Griffin MF, Huber J, Evan FJ, Quarto N, Longaker MT. The role of Wnt signaling in skin fibrosis.Med Res Rev. 20212;42:615–28. [DOI] [PubMed]
Fu K, Zheng X, Chen Y, Wu L, Yang Z, Chen X, et al. Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets.Front Pharmacol. 2022;13:1050630. [DOI] [PubMed] [PMC]
Jones JI, Nguyen TT, Peng Z, Chang M. Targeting MMP-9 in Diabetic Foot Ulcers.Pharmaceuticals (Basel). 2019;12:79. [DOI] [PubMed] [PMC]
Chang M. Targeting Matrix Metalloproteinase-9 for Therapeutic Intervention in Diabetic Foot Ulcers.ACS Pharmacol Transl Sci. 2024;7:2901–11. [DOI] [PubMed] [PMC]
Huang K, Mi B, Xiong Y, Fu Z, Zhou W, Liu W, et al. Angiogenesis during diabetic wound repair: from mechanism to therapy opportunity.Burns Trauma. 2025;13:tkae052. [DOI] [PubMed] [PMC]
Tecilazich F, Dinh T, Pradhan-Nabzdyk L, Leal E, Tellechea A, Kafanas A, et al. Role of Endothelial Progenitor Cells and Inflammatory Cytokines in Healing of Diabetic Foot Ulcers.PLoS ONE. 2013;8:e83314. [DOI] [PubMed] [PMC]
Liu Y, Liu Y, Deng J, Li W, Nie X. Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects.Front Endocrinol (Lausanne). 2021;12:744868. [DOI] [PubMed] [PMC]
AbuHaweeleh MN, Ali S, Elsalakawi Y, Al-Khulaifi A, Maggio V, Rizzo M, et al. Unravelling the pathophysiology of diabetic foot ulcer: insights into a complex wound healing process.Front Clin Diabetes Healthc. 2026;7:1759605. [DOI] [PubMed] [PMC]
Lin H, Yang Y, Wang X, Chung M, Zhang L, Cai S, et al. Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing.Front Med (Lausanne). 2025;12:1667620. [DOI] [PubMed] [PMC]
Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG, et al. The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing.Oxid Med Cell Longev. 2021;2021:8852759. [DOI] [PubMed] [PMC]
Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.Ann N Y Acad Sci. 2011;1243:88–102. [DOI] [PubMed] [PMC]
Dai J, Chen H, Chai Y. Advanced Glycation End Products (AGEs) Induce Apoptosis of Fibroblasts by Activation of NLRP3 Inflammasome via Reactive Oxygen Species (ROS) Signaling Pathway.Med Sci Monit. 2019;25:7499–508. [DOI] [PubMed] [PMC]
Lou J, Xiang Z, Zhu X, Li J, Jin G, Cui S, et al. Skin microbiota and diabetic foot ulcers.Front Microbiol. 2025;16:1575081. [DOI] [PubMed] [PMC]
Wang Q, Liu C, An J, Liu J, Wang Y, Cai Y. Mechanisms of microbial infection and wound healing in diabetic foot ulcer: pathogenicity in the inflammatory-proliferative phase, chronicity, and treatment strategies.Front Endocrinol (Lausanne). 2025;16:1657928. [DOI] [PubMed] [PMC]
Versey Z, da Cruz Nizer WS, Russell E, Zigic S, DeZeeuw KG, Marek JE, et al. Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation.Front Immunol. 2021;12:648554. [DOI] [PubMed] [PMC]
Cavallo I, Sivori F, Mastrofrancesco A, Abril E, Pontone M, Di Domenico EG, et al. Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches.Biology (Basel). 2024;13:109. [DOI] [PubMed] [PMC]
Lin CW, Hung CM, Chen WJ, Chen JC, Huang WY, Lu CS, et al. New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers.Pharmaceutics. 2022;14:2065. [DOI] [PubMed] [PMC]
Özsezer G, Arslan YE. Immunomodulatory Tissue‐Engineering Strategies for Diabetic Foot Ulcer Management: A Systematic Review.Wound Repair Regen. 2026;34:e70149. [DOI] [PubMed] [PMC]
Xiong Y, Feng Q, Lu L, Zha K, Yu T, Lin Z, et al. Immunomodulatory Hydrogels: Advanced Regenerative Tools for Diabetic Foot Ulcer.Adv Funct Mater. 2023;33:2213066. [DOI]
Adhikary K, Sarkar R, Maity S, Sadhukhan I, Sarkar R, Ganguly K, et al. Immunomodulation of Macrophages in Diabetic Wound Individuals by Structurally Diverse Bioactive Phytochemicals.Pharmaceuticals (Basel). 2024;17:1294. [DOI] [PubMed] [PMC]
Mahmoudvand G, Karimi Rouzbahani A, Razavi ZS, Mahjoor M, Afkhami H. Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight.Front Bioeng Biotechnol. 2023;11:1158484. [DOI] [PubMed] [PMC]
Cao J, Zhang X, Li Z, Zhang S, Guo L, Liu Z, et al. Adipose-Derived Mesenchymal Stem Cells Accelerate Diabetic Foot Ulcer Healing by Promoting Macrophage M2 Polarization Through Downregulation of EREG and CSTA.J Inflamm Res. 2025;18:7749–68. [DOI] [PubMed] [PMC]
Huang YY, Lin CW, Cheng NC, Cazzell SM, Chen HH, Huang KF, et al. Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.JAMA Netw Open. 2021;4:e2122607. [DOI] [PubMed] [PMC]
Yan W, Ni T, Zhang Q, Sun X, Xu Z, Li X, et al. MCC950 promotes diabetic wound healing through modulating macrophage polarization in an MDSC-dependent manner.Int Immunopharmacol. 2024;142:112983. [DOI] [PubMed]
Ding Y, Yang P, Li S, Zhang H, Ding X, Tan Q. Resveratrol accelerates wound healing by inducing M2 macrophage polarisation in diabetic mice.Pharm Biol. 2022;60:2328–37. [DOI] [PubMed] [PMC]
Li S, Yang P, Ding X, Zhang H, Ding Y, Tan Q. Puerarin improves diabetic wound healing via regulation of macrophage M2 polarization phenotype.Burns Trauma. 2022;10:tkac046. [DOI] [PubMed] [PMC]
Yang Y, Zhang B, Yang Y, Peng B, Ye R. FOXM1 accelerates wound healing in diabetic foot ulcer by inducing M2 macrophage polarization through a mechanism involving SEMA3C/NRP2/Hedgehog signaling.Diabetes Res Clin Pract. 2022;184:109121. [DOI] [PubMed]
Qi X, Cai E, Xiang Y, Zhang C, Ge X, Wang J, et al. An Immunomodulatory Hydrogel by Hyperthermia‐Assisted Self‐Cascade Glucose Depletion and ROS Scavenging for Diabetic Foot Ulcer Wound Therapeutics.Adv Mater. 2023;35:e2306632. [DOI] [PubMed]
Boodhoo K, Vlok M, van de Vyver M. A Macrophage‐Based Cell Therapy Approach Promotes Collagen Deposition in Diabetic Wounds.Wound Repair Regen. 2025;33:e70071. [DOI] [PubMed] [PMC]
Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes.Science. 2020;367:eaau6977. [DOI] [PubMed] [PMC]
Zeng J, Sun Z, Zeng F, Gu C, Chen X. M2 macrophage-derived exosome-encapsulated microneedles with mild photothermal therapy for accelerated diabetic wound healing.Mater Today Bio. 2023;20:100649. [DOI] [PubMed] [PMC]
Yang H, Xu H, Wang Z, Li X, Wang P, Cao X, et al. Analysis of miR-203a-3p/SOCS3-mediated induction of M2 macrophage polarization to promote diabetic wound healing based on epidermal stem cell-derived exosomes.Diabetes Res Clin Pract. 2023;197:110573. [DOI] [PubMed]
Yin D, Shen G. Exosomes from adipose‐derived stem cells regulate macrophage polarization and accelerate diabetic wound healing via the circ‐Rps5/miR‐124‐3p axis.Immun Inflamm Dis. 2024;12:e1274. [DOI] [PubMed] [PMC]
Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway.Stem Cell Res Ther. 2020;11:259. [DOI] [PubMed] [PMC]
Mehnath S, Karthikeyan K, Jeyaraj M. Mechanical Force on Hydrogel Implication on Enhanced Drug Release, Antibacterial, and M2 Macrophage Polarization: New Insights Alleviate Diabetic Wound Healing.ACS Appl Mater Interfaces. 2024;16:55166–80. [DOI] [PubMed]
Chen SG, Chu ST, Pu CM, Chen JC, Wu YH. 100-OR: A Novel Macrophage-Regulation Drug for Treating Diabetic Foot Ulcer—A Phase III MRCT Study and Taiwan Experience.Diabetes. 2023;72:100-OR. [DOI]
Alam A, Momi S, Riyaz H, Behado O, Rai V. Impaired cytokines in diabetes and diabetic foot ulcers: mechanisms and prospects.Explor Endocr Metab Dis. 2026;3:101457. [DOI]
Goren I, Müller E, Schiefelbein D, Christen U, Pfeilschifter J, Mühl H, et al. Systemic Anti-TNFα Treatment Restores Diabetes-Impaired Skin Repair in ob/ob Mice by Inactivation of Macrophages.J Invest Dermatol. 2007;127:2259–67. [DOI] [PubMed]
Cao Y, Harvey BP, Jin L, Westmoreland S, Wang J, Puri M, et al. Therapeutic TNF Inhibitors Exhibit Differential Levels of Efficacy in Accelerating Cutaneous Wound Healing.JID Innov. 2024;4:100250. [DOI] [PubMed] [PMC]
Dogra S, Khullar G. Tumor necrosis factor-α antagonists: Side effects and their management.Indian J Dermatol Venereol Leprol. 2013;79:S35–46. [DOI] [PubMed]
Arora A, Mahajan A, Spurden D, Boyd H, Porter D. Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug Registers.Int J Rheumatol. 2013;2013:764518. [DOI] [PubMed] [PMC]
Minozzi S, Bonovas S, Lytras T, Pecoraro V, González-Lorenzo M, Bastiampillai AJ, et al. Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.Expert Opin Drug Saf. 2016;15:11–34. [DOI] [PubMed]
Crawford M, Curtis JR. Tumor necrosis factor inhibitors and infection complications.Curr Rheumatol Rep. 2008;10:383–9. [DOI] [PubMed] [PMC]
Gan MS, Yang B, Fang DL, Wu BL. IL-1B can serve as a healing process and is a critical regulator of diabetic foot ulcer.Ann Transl Med. 2022;10:179. [DOI] [PubMed] [PMC]
Dai J, Shen J, Chai Y, Chen H. IL-1β Impaired Diabetic Wound Healing by Regulating MMP-2 and MMP-9 through the p38 Pathway.Mediators Inflamm. 2021;2021:6645766. [DOI] [PubMed] [PMC]
Mirza RE, Fang MM, Ennis WJ, Koh TJ. Blocking Interleukin-1β Induces a Healing-Associated Wound Macrophage Phenotype and Improves Healing in Type 2 Diabetes.Diabetes. 2013;62:2579–87. [DOI] [PubMed] [PMC]
Perrault DP, Bramos A, Xu X, Shi S, Wong AK. Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing.Ann Plast Surg. 2018;80:S317–21. [DOI] [PubMed] [PMC]
Tan JL, Lash B, Karami R, Nayer B, Lu YZ, Piotto C, et al. Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist.Commun Biol. 2021;4:422. [DOI] [PubMed] [PMC]
Kolumam G, Wu X, Lee WP, Hackney JA, Zavala-Solorio J, Gandham V, et al. IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice.PLOS ONE. 2017;12:e0170639. [DOI] [PubMed] [PMC]
Gao M, Nguyen TT, Suckow MA, Wolter WR, Gooyit M, Mobashery S, et al. Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy.Proc Natl Acad Sci U S A. 2015;112:15226–31. [DOI] [PubMed] [PMC]
Peng Z, Nguyen TT, Song W, Anderson B, Wolter WR, Schroeder VA, et al. Selective MMP-9 Inhibitor (R)-ND-336 Alone or in Combination with Linezolid Accelerates Wound Healing in Infected Diabetic Mice.ACS Pharmacol Transl Sci. 2020;4:107–17. [DOI] [PubMed] [PMC]
Dissemond J, Augustin M, Dietlein M, Faust U, Keuthage W, Lobmann R, et al. Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review.J Wound Care. 2020;29:102–18. [DOI] [PubMed]
Song J, Liu A, Liu B, Huang W, Jiang Z, Bai X, et al. Natural Biologics Accelerate Healing of Diabetic Foot Ulcers by Regulating Oxidative Stress.Front Biosci-Landmark. 2022;27:285. [DOI] [PubMed]
Wang Q, Zhu G, Cao X, Dong J, Song F, Niu Y. Blocking AGE-RAGE Signaling Improved Functional Disorders of Macrophages in Diabetic Wound.J Diabetes Res. 2017;2017:1428537. [DOI] [PubMed] [PMC]
Theophall GG, Manigrasso MB, Nazarian P, Premo A, Reverdatto S, Yepuri G, et al. RAGE-mediated activation of the formin DIAPH1 and human macrophage inflammation are inhibited by a small molecule antagonist.Cell Chem Biol. 2025;32:1221–34.e8. [DOI] [PubMed] [PMC]
Yu W, Xu H, Yuan X, Chen W, Hao Y, Zhao G. Cinnamaldehyde promotes diabetic wound healing via synergetic effects of AGE/RAGE-mediated macrophage polarization affecting fibroblast activation and angiogenesis, and Nrf2-dependent antioxidants.Biochem Biophys Res Commun. 2025;781:152519. [DOI] [PubMed]
Jin X, Li A, Dai Z, Li Y, Feng X, Qiu F. Resina Draconis Promotes Diabetic Wound Healing by Regulating the AGE-RAGE Pathway to Modulate Macrophage Polarization.Curr Issues Mol Biol. 2025;47:748. [DOI] [PubMed] [PMC]
Manigrasso MB, Rabbani P, Egaña-Gorroño L, Quadri N, Frye L, Zhou B, et al. Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice.Sci Transl Med. 2021;13:eabf7084. [DOI] [PubMed] [PMC]
Wang W, Liu X, Xiao J, Zhang Y, Hao Y, Hou R, et al. Breathable palladium hydride hydrogels mediated “head and tail” co-blocking HMGB1-RAGE axis strategy for diabetic foot ulcer treatment.Nano Today. 2025;65:102815. [DOI]
Zhang S, Xu Y, Zhang Junior C, Chen X, Zhu J. Dang-Gui-Si-Ni decoction facilitates wound healing in diabetic foot ulcers by regulating expression of AGEs/RAGE/TGF-β/Smad2/3.Arch Dermatol Res. 2024;316:338. [DOI] [PubMed]
Tang G, Wang Y, Deng P, Wu J, Lu Z, Zhu R, et al. Mechanism of dracorhodin in accelerating diabetic foot ulcer healing via the Nrf2 pathway, a network pharmacology, molecular docking and experimental validation.Sci Rep. 2025;15:12492. [DOI] [PubMed] [PMC]
Banerjee A, Singh P, Sheikh PA, Kumar A, Koul V, Bhattacharyya J. Simultaneous regulation of AGE/RAGE signaling and MMP-9 expression by an immunomodulating hydrogel accelerates healing in diabetic wounds.Biomater Adv. 2024;163:213937. [DOI] [PubMed]
Yang Y, Huang S, Ma Q, Li N, Li R, Wang Y, et al. Combined therapeutic strategy based on blocking the deleterious effects of AGEs for accelerating diabetic wound healing.Regen Biomater. 2024;11:rbae062. [DOI] [PubMed] [PMC]
Zhao L, Chen S, Chen S, Sun Y, Xi L, Huang S, et al. Self-regulating hydrogel for diabetic wound healing: From animal models to a pilot clinical study.Sci Adv. 2026;12:eaed4981. [DOI] [PubMed] [PMC]
Wang R, Li B, Dong M, Zhu H, Jin P, Zou Y. Targeting oxidative damage in diabetic foot ulcers: integrative strategies involving antioxidant drugs and nanotechnologies.Burns Trauma. 2025;13:tkaf020. [DOI] [PubMed] [PMC]
Pérez-Vielma NM, Valencia Gutiérrez MM, Sánchez Camacho JV, González Hernández JE, García ÁM, Ochoa C, et al. The effect of hyperbaric oxygen therapy on oxidative stress and inflammation in patients with diabetic foot ulcers: A preliminary study.Heliyon. 2024;10:e40586. [DOI] [PubMed] [PMC]
Zhou Q, Chi J, Yang J, Dong X, Guo J, Lian F, et al. Natural, safety immunomodulatory derivatives of lactobacillus biofilms promote diabetic wound healing by metabolically regulating macrophage phenotype and alleviating local inflammation.J Adv Res. 2026;79:917–33. [DOI] [PubMed] [PMC]
Supardy NA, Kumar RRS. Aging, biofilms, and diabetic foot ulcers: disrupting chronic infections with super-oxidized solutions and addressing age-related vulnerabilities.Cardiovasc Diabetol – Endocrinol Rep. 2025;11:45. [DOI] [PubMed] [PMC]
Zhou L, Zhang Y, Ge Y, Zhu X, Pan J. Regulatory Mechanisms and Promising Applications of Quorum Sensing-Inhibiting Agents in Control of Bacterial Biofilm Formation.Front Microbiol. 2020;11:589640. [DOI] [PubMed] [PMC]
Mashamba TG, Adeosun IJ, Baloyi IT, Tshikalange ET, Cosa S. Quorum sensing modulation and inhibition in biofilm forming foot ulcer pathogens by selected medicinal plants.Heliyon. 2022;8:e09303. [DOI] [PubMed] [PMC]
Astrada A, Nakagami G, Kashiwabara K, Sanada H. Biofilm detection-based wound management in diabetic foot ulcers: a randomised controlled trial.J Wound Care. 2025;34:514–24. [DOI] [PubMed]
Dai Y, Chen Y. Targeting persistently activated inflammatory microenvironment to promote chronic wound healing.Front Immunol. 2025;16:1708358. [DOI] [PubMed] [PMC]
Monaghan MG, Borah R, Thomsen C, Browne S. Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment.Adv Drug Deliv Rev. 2023;203:115120. [DOI] [PubMed]
Feng JY, Ju S. Four key inflammatory pathways and targets in diabetic foot ulcers explored through data-driven analysis.J Vasc Surg: Venous Lymphat Disord. 2026;14:102304. [DOI] [PubMed] [PMC]
Omotosho IA, Shamsuddin N, Zaman Huri H, Chong WL, Rehman IU. From Control to Cure: Insights into the Synergy of Glycemic and Antibiotic Management in Modulating the Severity and Outcomes of Diabetic Foot Ulcers.Int J Mol Sci. 2025;26:6909. [DOI] [PubMed] [PMC]
Pouget C, Dunyach-Remy C, Pantel A, Schuldiner S, Sotto A, Lavigne JP. Biofilms in Diabetic Foot Ulcers: Significance and Clinical Relevance.Microorganisms. 2020;8:1580. [DOI] [PubMed] [PMC]
Ruke M, Savai J. Diabetic Foot Infection, Biofilm & New Management Strategy.Diabetes Res: Open Access. 2019;1:7–22. [DOI]
Theodorakopoulos G, Armstrong DG. Biofilm in Diabetic Foot Ulcers: A Systematic Narrative Review.Int Wound J. 2025;22:e70795. [DOI] [PubMed] [PMC]
Shen AZ, Taha M, Ghannoum M, Tyring SK. Biofilms and Chronic Wounds: Pathogenesis and Treatment Options.J Clin Med. 2025;14:7784. [DOI] [PubMed] [PMC]
Lipsky BA, Uçkay İ. Treating Diabetic Foot Osteomyelitis: A Practical State-of-the-Art Update.Medicina. 2021;57:339. [DOI] [PubMed] [PMC]
Hockney SM, Steker D, Bhasin A, Krueger KM, Williams J, Galvin S. Role of bone biopsy and deep tissue culture for antibiotic stewardship in diabetic foot osteomyelitis.J Antimicrob Chemother. 2022;77:3482–6. [DOI] [PubMed] [PMC]
Hajimohammadi K, Parizad N, Hassanpour A, Goli R. Saving diabetic foot ulcers from amputation by surgical debridement and maggot therapy: A case report.Int J Surg Case Rep. 2021;86:106334. [DOI] [PubMed] [PMC]
Isaac AL, Tritto M. Use of a Novel Purified Reconstituted Bilayer Matrix for Treatment of Chronic Diabetic Foot Ulcers: A Retrospective Case Series.Wounds: compend clin res pract. 2023;35:E29–34. [DOI] [PubMed]
Babamiri B, Faramarzi MR, Taraj SK, Faraji N, Goli R, Mohammadi F. Healing of a diabetic foot wound through surgical debridement using med-honey, maggot therapy, and human amniotic membrane: A case study.Int J Surg Case Rep. 2024;122:110041. [DOI] [PubMed] [PMC]
Burhan A, Firdaus EK, Sebayang SM, O'Really C, Susanti I, Sumarni R, et al. Comparative Effectiveness of Debridement Methods on Wound Healing Outcomes in Diabetic Foot Ulcers: A Systematic Review and Bayesian Network Meta‐Analysis.Wound Repair Regen. 2026;34:e70164. [DOI] [PubMed]
Ning P, Liu Y, Kang J, Cao H, Zhang J. Comparison of healing effectiveness of different debridement approaches for diabetic foot ulcers: a network meta-analysis of randomized controlled trials.Front Public Health. 2023;11:1271706. [DOI] [PubMed] [PMC]
Liu Q, Yu X. Advanced Natural Therapeutics and Delivery Strategies for Diabetic Foot Ulcers: A Mini Review.Drug Des Dev Ther. 2025;19:10449–72. [DOI] [PubMed] [PMC]
Frangogiannis NG. Why animal model studies are lost in translation.J Cardiovasc Aging. 2022;2. [DOI] [PubMed] [PMC]
Hartung T. Look back in anger – what clinical studies tell us about preclinical work.ALTEX. 2013;30:275–91. [DOI] [PubMed] [PMC]
Mahalmani V, Prakash A, Medhi B. Do alternatives to animal experimentation replace preclinical research?Indian J Pharmacol. 2023;55:71–5. [DOI] [PubMed] [PMC]
Aban IB, George B. Statistical considerations for preclinical studies.Exp Neurol. 2015;270:82–7. [DOI] [PubMed] [PMC]
Spanagel R. Ten Points to Improve Reproducibility and Translation of Animal Research.Front Behav Neurosci. 2022;16:869511. [DOI] [PubMed] [PMC]
Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, et al. Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.Int J Mol Sci. 2024;25:13121. [DOI] [PubMed] [PMC]
Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it?Acta Pharm Sin B. 2022;12:3049–62. [DOI] [PubMed] [PMC]
Mehta K, Maass C, Cucurull-Sanchez L, Pichardo-Almarza C, Subramanian K, Androulakis IP, et al. Modernizing Preclinical Drug Development: The Role of New Approach Methodologies.ACS Pharmacol Transl Sci. 2025;8:1513–25. [DOI] [PubMed] [PMC]
Kim HK, Kim SJ, Gil WJ, Yang CS. Exploring the therapeutic potential of phytochemicals: challenges and strategies for clinical translation.Phytomedicine. 2025;145:157090. [DOI] [PubMed]
Aqil F, Munagala R, Jeyabalan J, Vadhanam MV. Bioavailability of phytochemicals and its enhancement by drug delivery systems.Cancer Lett. 2013;334:133–41. [DOI] [PubMed] [PMC]
Yu D, Park J, Kim T, Choi C, Yuk SA, Kim H. Nanotechnology-Enabled Delivery of Phytochemicals: From Formulation Strategies to Therapeutic Translation.J Phytomed. 2026;1:4. [DOI]
Omidian H, Chowdhury SD, Wilson RL. Advancements and Challenges in Hydrogel Engineering for Regenerative Medicine.Gels. 2024;10:238. [DOI] [PubMed] [PMC]
Xu F, Dawson C, Lamb M, Mueller E, Stefanek E, Akbari M, et al. Hydrogels for Tissue Engineering: Addressing Key Design Needs Toward Clinical Translation.Front Bioeng Biotechnol. 2022;10:849831. [DOI] [PubMed] [PMC]
Grounds MD. Obstacles and challenges for tissue engineering and regenerative medicine: Australian nuances.Clin Exp Pharmacol Physiol. 2018;45:390–400. [DOI] [PubMed]
Pacelli S, Basu S, Whitlow J, Chakravarti A, Acosta F, Varshney A, et al. Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.Adv Drug Deliv Rev. 2017;120:50–70. [DOI] [PubMed] [PMC]
Chen S, Zhang L, Ren Y, Bai X, Wei X, Chai M, et al. Clinical translational research on stem cell products: prospects and challenges.Signal Transduct Target Ther. 2026;11:178. [DOI] [PubMed] [PMC]
Farjaminejad R, Farjaminejad S, Garcia-Godoy F, Marya A, Nucci L, Jamilian A. Advances and Challenges in Tissue Engineering: Biomaterials, Cellular Strategies, and Clinical Applications.J Funct Biomater. 2026;17:184. [DOI] [PubMed] [PMC]
Tripathi D, Pandey P, Sharma S, Rai AK, Prabhu B H M. Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity.BioImpacts. 2025;15:30573. [DOI] [PubMed] [PMC]
Zheng C, Li M, Ding J. Challenges and Opportunities of Nanomedicines in Clinical Translation.BIO Integr. 2021;2:57–60. [DOI]
Hu C, He X, Gao H, Zhang J. DELIVER: The core principles for the clinic translation of nanomedicines.Acta Pharm Sin B. 2025;15:1196–8. [DOI] [PubMed] [PMC]
Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, et al. Current hurdles to the translation of nanomedicines from bench to the clinic.Drug Deliv Transl Res. 20212;12:500–25. [DOI] [PubMed] [PMC]
Yash, Dharmani B, Kaur R, Choudhary D, Bhatia R, Kumar A, et al. Challenges in translating nanotechnology from research to clinical practice.Adv Cancer Res. 2026;169:235–57. [DOI] [PubMed]
Chen YF, Luh F, Ho YS, Yen Y. Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials.J Biomed Sci. 2024;31:67. [DOI] [PubMed] [PMC]
Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S, et al. A comprehensive review of challenges and advances in exosome-based drug delivery systems.Nanoscale Adv. 2024;6:5803–26. [DOI] [PubMed] [PMC]
Tzng E, Bayardo N, Yang PC. Current challenges surrounding exosome treatments.Extracell Vesicle. 2023;2:100023. [DOI] [PubMed] [PMC]
Ge X, Shan S, Lu H, Wang W, Gao C, Fu S. Strategies, Challenges and Application Prospects for Exosome Engineering Modifications in Tumor Targeted Therapeutics.Int J Nanomedicine. 2026;21:572435. [DOI] [PubMed] [PMC]
Soltanmohammadi F, Maghsoodi M, Alizadeh E, Adibkia K, Azarmi Y, Mahmoudi Gharehbaba A, et al. Bio fluid exosomes: promises, challenges, and future directions in translational medicine.J Transl Med. 2025;23:993. [DOI] [PubMed] [PMC]
Chen YS, Lin EY, Chiou TW, Harn HJ. Exosomes in clinical trial and their production in compliance with good manufacturing practice.Tzu Chi Med J. 2020;32:113–20. [DOI] [PubMed] [PMC]
Drude NI, Martinez Gamboa L, Danziger M, Dirnagl U, Toelch U. Improving preclinical studies through replications.eLife. 2021;10:e62101. [DOI] [PubMed] [PMC]
Khalil AS, Jaenisch R, Mooney DJ. Engineered tissues and strategies to overcome challenges in drug development.Adv Drug Deliv Rev. 2020;158:116–39. [DOI] [PubMed] [PMC]